Legis Daily

Blocking Deadly Fentanyl Imports Act

USA116th CongressHR-1098| House 
| Updated: 2/7/2019
F. James Sensenbrenner

F. James Sensenbrenner

Republican Representative

Wisconsin

Cosponsors (13)
Mark Meadows (Republican)Guy Reschenthaler (Republican)Scott Perry (Republican)Lloyd Smucker (Republican)Daniel Meuser (Republican)Matt Cartwright (Democratic)Mike Kelly (Republican)John Joyce (Republican)Conor Lamb (Democratic)Ron Wright (Republican)Brian K. Fitzpatrick (Republican)Gerald E. Connolly (Democratic)Fred Keller (Republican)

Foreign Affairs Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Blocking Deadly Fentanyl Imports Act This bill expands reporting requirements related to foreign countries that produce illicit fentanyl and limits assistance to countries that fail to take various actions to combat illegal drug production and trafficking. The President's annual report to Congress on U.S. strategy for controlling international narcotics shall include a section that identifies the countries that are the most significant sources of illicit fentanyl, fentanyl analogues, and precursor chemicals used for producing fentanyl. The report shall also describe the extent to which such a country has cooperated with U.S. efforts to prevent exports of such substances into the United States. The United States shall withhold 50% of the foreign assistance allocated to each identified country for the fiscal year. The Department of the Treasury shall also direct U.S. Executive Directors in each multilateral development bank to vote against making loans or allocating funds to such countries. Both restrictions may be waived if the President certifies that the country has cooperated fully with U.S. anti-drug trafficking efforts or if vital U.S. national interests necessitate such a waiver. The bill also directs the President to identify countries that (1) have not adopted various procedures for countering narcotics production and distribution, or (2) are incapable of prosecuting individuals that manufacture or distribute new types of drugs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 7, 2019

Latest Companion Bill Action

S 116-400
Introduced in Senate
Feb 7, 2019
Introduced in House
Feb 7, 2019
Referred to the House Committee on Foreign Affairs.
  • February 7, 2019

    Latest Companion Bill Action

    S 116-400
    Introduced in Senate


  • February 7, 2019
    Introduced in House


  • February 7, 2019
    Referred to the House Committee on Foreign Affairs.

International Affairs

Related Bills

  • S 116-400: Blocking Deadly Fentanyl Imports Act
Congressional oversightCriminal investigation, prosecution, interrogationDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesForeign aid and international reliefLicensing and registrationsTrade restrictions

Blocking Deadly Fentanyl Imports Act

USA116th CongressHR-1098| House 
| Updated: 2/7/2019
Blocking Deadly Fentanyl Imports Act This bill expands reporting requirements related to foreign countries that produce illicit fentanyl and limits assistance to countries that fail to take various actions to combat illegal drug production and trafficking. The President's annual report to Congress on U.S. strategy for controlling international narcotics shall include a section that identifies the countries that are the most significant sources of illicit fentanyl, fentanyl analogues, and precursor chemicals used for producing fentanyl. The report shall also describe the extent to which such a country has cooperated with U.S. efforts to prevent exports of such substances into the United States. The United States shall withhold 50% of the foreign assistance allocated to each identified country for the fiscal year. The Department of the Treasury shall also direct U.S. Executive Directors in each multilateral development bank to vote against making loans or allocating funds to such countries. Both restrictions may be waived if the President certifies that the country has cooperated fully with U.S. anti-drug trafficking efforts or if vital U.S. national interests necessitate such a waiver. The bill also directs the President to identify countries that (1) have not adopted various procedures for countering narcotics production and distribution, or (2) are incapable of prosecuting individuals that manufacture or distribute new types of drugs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 7, 2019

Latest Companion Bill Action

S 116-400
Introduced in Senate
Feb 7, 2019
Introduced in House
Feb 7, 2019
Referred to the House Committee on Foreign Affairs.
  • February 7, 2019

    Latest Companion Bill Action

    S 116-400
    Introduced in Senate


  • February 7, 2019
    Introduced in House


  • February 7, 2019
    Referred to the House Committee on Foreign Affairs.
F. James Sensenbrenner

F. James Sensenbrenner

Republican Representative

Wisconsin

Cosponsors (13)
Mark Meadows (Republican)Guy Reschenthaler (Republican)Scott Perry (Republican)Lloyd Smucker (Republican)Daniel Meuser (Republican)Matt Cartwright (Democratic)Mike Kelly (Republican)John Joyce (Republican)Conor Lamb (Democratic)Ron Wright (Republican)Brian K. Fitzpatrick (Republican)Gerald E. Connolly (Democratic)Fred Keller (Republican)

Foreign Affairs Committee

International Affairs

Related Bills

  • S 116-400: Blocking Deadly Fentanyl Imports Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Congressional oversightCriminal investigation, prosecution, interrogationDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesForeign aid and international reliefLicensing and registrationsTrade restrictions